Actively Recruiting

Age: 0 - 28Days
All Genders
ID02544100

Neonatal Neurologic Intensive Care Network of China

Led by Children's Hospital of Fudan University · Updated on 2025-09-05

2000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

C

Children's Hospital of Fudan University

Lead Sponsor

X

Xiamen Children's Hospital, Fujian of China

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are creating a Neonatal Neurologic Intensive Care Network in China to collect and analyze large-scale data on newborns with severe encephalopathy. This network gathers detailed neonatal information including demographics, medical history, family background, perinatal details, birth, growth, feeding status, imaging, biological samples, and genetic data. The goal is to use big data to monitor brain function, predict brain injuries, and suggest appropriate treatments. Seven children's hospitals from six provinces in China are participating in this collaborative effort. Participants in this observational study will have their systematic medical information entered into a comprehensive database. Biological samples such as blood, urine, and cerebrospinal fluid (CSF) will be collected and stored in a biobank for future research. This sample collection occurs within 72 hours after birth. The study involves continuous follow-up during the hospital stay, with an expected average duration of about four weeks. During the study, electronic medical records will be monitored for the hospital stay duration. Neurodevelopmental outcomes will be assessed using Bayley Scores and neurological evaluations with GMFM-88 Scores at 18 months of age. Gene mutation analysis will be conducted at 28 days. The study will track the number of blood and urine samples collected within the first 72 hours and record various clinical and biological data to support ongoing and future research in neonatal brain injury and care.

CONDITIONS

Brief Title

Neonatal Neurologic Intensive Care Network of China

Who Can Participate

Age: 0 - 28Days
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Postnatal age 28 days or younger
  • Written informed consent of parent or guardian
  • Diagnosis of one or more of the following: hypoxic ischemic encephalopathy (HIE), hydrocephalus, hypotonia, interventricular hemorrhages, intracranial calcifications, intracranial hemorrhages, meningitis or other brain infections, metabolic diseases, microcephaly, neonatal stroke, spina bifida, cerebral arteriovenous malformations (AVMs), or congenital brain malformations
Not Eligible

You will not qualify if you...

  • Known major congenital anomalies not related to neurologic disease
  • Unable to obtain sufficient biosample volume or sample collection failed
  • Parents refuse to provide consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Observational Monitoring

Duration - Approximately 4 weeks during hospital stay

Participants with neonatal severe encephalopathy have systematic medical information collected and biological samples (blood, urine, cerebrospinal fluid) gathered for research purposes.

Multiple visits during hospital stay

Long-term Monitoring

Duration - Up to 18 months

Participants' neurodevelopment and neurological status are assessed at 18 months of age, and gene mutation analysis is completed by 28 days.

Assessments at 28 days and 18 months

Trial Site Locations

Total: 1 location

1

Children Hospital of Fudan University

Shanghai, Shanghai Municipality, China, 201102

Actively Recruiting

Loading map...

Research Team

W

Wenhao Zhou, Doctor

G

Guoqiang Cheng, Doctor

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Phase IIb Dose Escalation Study of Levetiracetam for the T...

Neonatal Seizure

Actively Recruiting

5 locations

A Multicenter, Randomized, Double-blind, Placebo-controlled ...

Hypoxic-Ischemic Encephalopathy

Actively Recruiting

4 locations

Whole-body Hypothermia Versus Normothermia in Mild Neonatal ...

Neonatal Encephalopathy

Actively Recruiting

39 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Building a pediatric neurocritical care program: a multidisciplinary approach to clinical practice and education from the intensive care unit to the outpatient clinic.

Mark S Wainwright, Michele Grimason, Joshua Goldstein...

https://pubmed.ncbi.nlm.nih.gov/25727506